{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Kevin+Hollinrake&max-date=2016-11-07&answer.answeringMemberPrinted=Jane+Ellison", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Kevin+Hollinrake&max-date=2016-11-07&answer.answeringMemberPrinted=Jane+Ellison", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Kevin+Hollinrake&max-date=2016-11-07&_metadata=all&answer.answeringMemberPrinted=Jane+Ellison", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Kevin+Hollinrake&_page=0&max-date=2016-11-07&answer.answeringMemberPrinted=Jane+Ellison", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Kevin+Hollinrake&max-date=2016-11-07&answer.answeringMemberPrinted=Jane+Ellison", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Kevin+Hollinrake&max-date=2016-11-07&answer.answeringMemberPrinted=Jane+Ellison", "items" : [{"_about" : "http://data.parliament.uk/resources/532958", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/532958/answer", "answerText" : {"_value" : "<p>The Government will work with the international community to develop and agree a system which encourages the pharmaceutical industry to develop new antibiotics in line with the recommendations made in the final report of the Review on Antimicrobial Resistance. The Department will meanwhile continue its ongoing dialogue with the Association of the British Pharmaceutical Industry on antibiotic pricing and reimbursement in the hope of reaching agreement by the end of the year on a set of potential options for a reimbursement model suitable for piloting in England.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2016-07-13", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-07-13T09:24:01.68Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-07-05", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Antibiotics: Drug Resistance"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, with reference to recommendation 9 of the final report of The Review on Antimicrobial Resistance, published in May 2016, whether and within what timescale the Government plans to consider possible changes to its purchase and distribution systems for antibiotics.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
      }
      , "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
      , "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
      ], "uin" : "41876"}
    , {"_about" : "http://data.parliament.uk/resources/528073", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/528073/answer", "answerText" : {"_value" : "<p>The Department takes advice on the measurement of prescribing levels and the development of objectives for levels of prescribing of antibiotics from the Department\u2019s Health\u2019s Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infections as well as the English Surveillance Programme for Antimicrobial Utilisation and Resistance.<\/p><p> <\/p><p>The English Surveillance Programme on Antimicrobial Use and Resistance, (ESPAUR), was established by Public Health England (PHE) in 2013 in response to the publication of the UK 5 year Strategy on Antimicrobial Resistance (AMR). ESPAUR provides the data on prescribing of antibiotics and levels of resistance to antibiotics in both primary and secondary care that allows the Department to evaluate progress.<\/p><p> <\/p><p>PHE uses the ESPAUR data to provide ongoing expert advice to NHS England to enable ongoing development of commissioning incentives to encourage healthcare providers to achieve the antibiotic prescribing quality measures recommended by the national expert Advisory Group on AMR and Healthcare Associated Infections for primary and secondary care.<\/p><p> <\/p><p>The Department\u2019s Policy Research Programme has also commissioned the Imperial National Institute for Health Research Health Protection Research Unit to evaluate and research the impact of reduced antibiotic prescribing on hospital admissions and mortality.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2016-07-04", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-07-04T14:20:19.833Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-06-20", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Antibiotics"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, by what process his Department plans to evaluate and continue to develop national antibiotic prescribing targets for primary and secondary care.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
      }
      , "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
      , "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
      ], "uin" : "41033"}
    , {"_about" : "http://data.parliament.uk/resources/514779", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/514779/answer", "answerText" : {"_value" : "<p>Departmental officials are in discussion with the Association of the British Pharmaceutical Industry regarding pricing and reimbursement models for antibiotics.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2016-04-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-29T12:40:37.817Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-04-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Antibiotics"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, whether his Department plans to reform the reimbursement of antibiotics.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
      }
      , "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
      , "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
      ], "uin" : "35027"}
    , {"_about" : "http://data.parliament.uk/resources/514782", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/514782/answer", "answerText" : {"_value" : "<p>Departmental officials are in discussion with the Association of the British Pharmaceutical Industry regarding pricing and reimbursement models for antibiotics. HM Treasury are aware of these discussions.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2016-04-29", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-04-29T12:47:10.26Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-04-21", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Antibiotics"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, whether his Department has had discussions with officials in HM Treasury on reforming the reimbursement of antibiotics.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
      }
      , "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
      , "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
      ], "uin" : "35012"}
    , {"_about" : "http://data.parliament.uk/resources/445979", "AnsweringBody" : [{"_value" : "Department of Health"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/445979/answer", "answerText" : {"_value" : "<p>The consultation on payment schemes for people given infected blood products was launched on 21 January 2016, on the same day I made an oral statement to the House, <em>Official Report<\/em>, columns 1583-85. The consultation is available at gov.uk.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
        }
        , "answeringMemberConstituency" : {"_value" : "Battersea"}
        , "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
        , "dateOfAnswer" : {"_value" : "2016-01-27", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-01-27T15:29:52.443Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health"}
      , "answeringDeptSortName" : {"_value" : "Health"}
      , "date" : {"_value" : "2016-01-19", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Blood: Contamination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health, pursuant to the Answer of 5 January 2016 to Question 20185, on what date his Department plans to publish the consultation and make an announcement on payment schemes for people affected by contaminated blood products.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4474", "label" : {"_value" : "Biography information for Kevin Hollinrake"}
      }
      , "tablingMemberConstituency" : {"_value" : "Thirsk and Malton"}
      , "tablingMemberPrinted" : [{"_value" : "Kevin Hollinrake"}
      ], "uin" : "23006"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}